v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net loss $ (61,372) $ (71,691)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,698 6,611
Stock-based compensation 7,447 14,535
Accretion and amortization of premiums and discounts on investments, net (1,536) (1,915)
Deferred revenue (382) (393)
Change in fair value of stock price appreciation milestones 660 (207)
Loss on disposal of property and equipment 0 (36)
Changes in operating assets and liabilities:    
Accounts receivable 213 2,144
Prepaid expenses and other assets 653 3,139
Accounts payable and accrued expenses (4,518) (9,342)
Right-of-use assets and lease liabilities, net (1,119) (1,241)
Net cash used in operating activities (54,256) (58,396)
Investing activities    
Proceeds from sale of property and equipment 0 122
Purchases of property and equipment (319) (2,558)
Purchases of investments (87,075) (99,437)
Maturities of investments 125,538 164,137
Net cash provided by investing activities 38,144 62,264
Financing activities    
Issuance of common stock from equity incentive plans, net of issuance costs 412 0
Proceeds from FT819 CIRM award 1,324 0
Proceeds from FT836 CIRM award 0 (1,325)
Net cash provided by financing activities 1,736 1,325
Net change in cash, cash equivalents and restricted cash (14,376) 5,193
Cash, cash equivalents and restricted cash at beginning of the period 56,855 46,283
Cash, cash equivalents and restricted cash at end of the period 42,479 51,476
Supplemental schedule of noncash investing and financing activities    
Purchases of property and equipment in accounts payable $ 0 $ 993